CIBINQO vs XELJANZ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 12, 2026·How we rate

Possible drug interaction. CIBINQO and XELJANZ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CIBINQO	XELJANZ
Rating	64/100	64/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ABROCITINIB	TOFACITINIB CITRATE
Manufacturer	Pfizer	Pfizer
Dosage forms	Tablet	Solution, Tablet
Drug class	Janus Kinase Inhibitor	Janus Kinase Inhibitor
Boxed warning	Boxed warning	Boxed warning
Treats	Atopic Dermatitis	Rheumatoid Arthritis

cibinqo xeljanz

Rating

64/100

Pharmacy pays

—

Type

Active ingredient

ABROCITINIB

TOFACITINIB CITRATE

Manufacturer

Pfizer

Dosage forms

Tablet

Solution, Tablet

Drug class

Janus Kinase Inhibitor

Boxed warning

Treats

Atopic Dermatitis

Rheumatoid Arthritis

Frequently asked questions

Which is better-rated, Cibinqo or Xeljanz?

Cibinqo and Xeljanz are tied at 3.2 out of 5 by our independent rating.

What is the difference between Cibinqo and Xeljanz?

Cibinqo contains Abrocitinib, while Xeljanz contains Tofacitinib Citrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.